Dudediligence.

CG Oncology, Inc

CGONNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$43,000Sep ’24$456,000Dec ’24$52,000Mar ’25$0.00Jun ’25$1.7MSep ’25$2.3MDec ’25$1.1MMar ’26$1.2MJun ’26
Net income, by quarter
−$20.4MSep ’24−$31.8MDec ’24−$34.5MMar ’25−$41.4MJun ’25−$43.8MSep ’25−$41.3MDec ’25−$60.2MMar ’26−$79.1MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$204,000$1.1M$4.0M
Operating incomenone on file−$55.4M−$114.7M−$190.8M
Net incomenone on file−$48.6M−$88.0M−$161.0M
Operating cash flownone on file−$45.7M−$78.7M−$132.3M
Free cash flownone on filenone on file−$78.9M−$132.5M
Cash$88.1M$8.3M$257.1M$32.5M
Debtnone on filenone on file$0.00$3.0M
Shares outstandingnone on file5.2M76.2M80.7M